test

Flynn Management LLC, its general partner

@Deerfield Management Company, L.p. (series C)

Latest period2024 - Q3ReportedManaged Assets$6.693BTotal holdings443
Assets growth rate11.36%Assets growth rate (2-Q avg)7.96%Continuous growth in asset value4 quarters

Portfolio positions

This chart displays the top 10 holdings in Deerfield Management Company, L.p. (series C)'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 443 positions.

Assets under management

The assets under management (AUM) of Deerfield Management Company, L.p. (series C) over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.693B in assets, with a quarterly growth rate of 11.36% and a 2-quarter average growth rate of 7.96%. The portfolio is managed by Flynn Management LLC, its general partner, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
EWTXEdgewise Therapeutics Inc
Recent Activity
Decreased -38.04%
0.72%
$47.535M
1.781M shares@ $26.69 avg price
BCAXBicara Therapeutics Inc
Recent Activity
New Position
0.69%
$45.723M
1.795M shares@ $25.48 avg price
CNMDConmed Corp
Recent Activity
Decreased -2.59%
0.67%
$44.223M
614,890 shares@ $71.93 avg price
GLPGGalapagos Nv
Recent Activity
0.61%
$40.623M
1.411M shares@ $28.79 avg price
COGTCogent Biosciences Inc
Recent Activity
0.61%
$40.438M
3.744M shares@ $10.8 avg price
ALNYAlnylam Pharmaceuticals Inc
Recent Activity
Increased 21.04%
0.6%
$39.879M
145,000 shares@ $275.03 avg price
EHABEnhabit Inc
Recent Activity
0.59%
$39.482M
4.998M shares@ $7.9 avg price
5165⤦Lantheus Hldgs Inc
Recent Activity
0.59%
$39.274M
25.255M shares@ $1.56 avg price
EMBCEmbecta Corp
Recent Activity
Increased 0.16%
0.58%
$38.498M
2.73M shares@ $14.1 avg price
PHVSPharvaris N V
Recent Activity
Increased 45.41%
0.57%
$37.627M
2.032M shares@ $18.52 avg price